| Device Classification Name |
Interoperable Automated Glycemic Controller
|
| 510(k) Number |
K232224 |
| Device Name |
iLet® Dosing Decision Software |
| Applicant |
| Beta Bionics, Inc. |
| 300 Baker Ave., Suite 301 |
|
Concord,
MA
01742
|
|
| Applicant Contact |
Liz Cooper |
| Correspondent |
| Beta Bionics, Inc. |
| 300 Baker Ave., Suite 301 |
|
Concord,
MA
01742
|
|
| Correspondent Contact |
Liz Cooper |
| Regulation Number | 862.1356 |
| Classification Product Code |
|
| Date Received | 07/27/2023 |
| Decision Date | 09/22/2023 |
| Decision |
Substantially Equivalent
(SESE) |
| Regulation Medical Specialty |
Clinical Chemistry
|
| 510k Review Panel |
Clinical Chemistry
|
| Summary |
Summary
|
| FDA Review |
Decision Summary
|
| Type |
Traditional
|
| Clinical Trials |
NCT04200313
|
| Reviewed by Third Party |
No
|
| Combination Product |
No
|
Predetermined Change Control Plan Authorized |
No
|
|
|